Elise A Biesboer, Abdul Hafiz Al Tannir, Leonard E Egede, Rebekah J Walker, Sneha Nagavally, Sarah A Endrizzi, William J Peppard
{"title":"城市三级医疗中心阿片类药物处方的驱动因素","authors":"Elise A Biesboer, Abdul Hafiz Al Tannir, Leonard E Egede, Rebekah J Walker, Sneha Nagavally, Sarah A Endrizzi, William J Peppard","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Froedtert & the Medical College of Wisconsin belongs to a minority of institutions in which opioids are more frequently prescribed to non-Hispanic Black patients than their non-Hispanic White counterparts. The objective of this study was to evaluate racial and ethnic differences in prescribing practices for Medicare patients to determine areas for intervention.</p><p><strong>Methods: </strong>This was a retrospective review of adult patients with Medicare insurance who received an ambulatory opioid prescription for pain. Outcomes included number of prescriptions, and maximum morphine milligram equivalent (MME). Unadjusted and adjusted linear regression models were used to examine associations between race and ethnicity and each outcome with and without adjustments for covariates.</p><p><strong>Results: </strong>A total of 17 105 patients were given an ambulatory opioid prescription over the study period. Although most prescriptions were provided to non-Hispanic White patients, non-Hispanic Black patients had a higher mean number of prescriptions (4.36; 95% CI, 4.08 - 4.63) and higher MMEs at 495.31 (95% CI , 445.72 - 544.91). After controlling for demographics and comorbidities, individual comorbidities emerged as independent variables associated with greater numbers of prescriptions, with sickle cell disease (β 9.86; 95% CI, 9.08-10.64; <i>P</i>P < 0.001), drug abuse (β 5.22; 95% CI, 4.96-5.48; <i>P</i>P < 0.001), and paralysis (β 2.20; 95% CI, 1.73-2.67; <i>P</i>P <0.001) having the strongest relationships, while after adjustment, the significance of race and ethnicity was lost.</p><p><strong>Conclusions: </strong>Institutions should explore reasons for racially inequitable opioid receipt. Individual comorbidities were associated with differences in opioid prescribing, allowing for targeted interventions in these patient groups.</p>","PeriodicalId":94268,"journal":{"name":"WMJ : official publication of the State Medical Society of Wisconsin","volume":"124 3","pages":"208-215"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Drivers of Opioid Prescriptions for Medicare Patients at an Urban Tertiary Center.\",\"authors\":\"Elise A Biesboer, Abdul Hafiz Al Tannir, Leonard E Egede, Rebekah J Walker, Sneha Nagavally, Sarah A Endrizzi, William J Peppard\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Froedtert & the Medical College of Wisconsin belongs to a minority of institutions in which opioids are more frequently prescribed to non-Hispanic Black patients than their non-Hispanic White counterparts. The objective of this study was to evaluate racial and ethnic differences in prescribing practices for Medicare patients to determine areas for intervention.</p><p><strong>Methods: </strong>This was a retrospective review of adult patients with Medicare insurance who received an ambulatory opioid prescription for pain. Outcomes included number of prescriptions, and maximum morphine milligram equivalent (MME). Unadjusted and adjusted linear regression models were used to examine associations between race and ethnicity and each outcome with and without adjustments for covariates.</p><p><strong>Results: </strong>A total of 17 105 patients were given an ambulatory opioid prescription over the study period. Although most prescriptions were provided to non-Hispanic White patients, non-Hispanic Black patients had a higher mean number of prescriptions (4.36; 95% CI, 4.08 - 4.63) and higher MMEs at 495.31 (95% CI , 445.72 - 544.91). After controlling for demographics and comorbidities, individual comorbidities emerged as independent variables associated with greater numbers of prescriptions, with sickle cell disease (β 9.86; 95% CI, 9.08-10.64; <i>P</i>P < 0.001), drug abuse (β 5.22; 95% CI, 4.96-5.48; <i>P</i>P < 0.001), and paralysis (β 2.20; 95% CI, 1.73-2.67; <i>P</i>P <0.001) having the strongest relationships, while after adjustment, the significance of race and ethnicity was lost.</p><p><strong>Conclusions: </strong>Institutions should explore reasons for racially inequitable opioid receipt. Individual comorbidities were associated with differences in opioid prescribing, allowing for targeted interventions in these patient groups.</p>\",\"PeriodicalId\":94268,\"journal\":{\"name\":\"WMJ : official publication of the State Medical Society of Wisconsin\",\"volume\":\"124 3\",\"pages\":\"208-215\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"WMJ : official publication of the State Medical Society of Wisconsin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"WMJ : official publication of the State Medical Society of Wisconsin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
简介:Froedtert & Medical College of Wisconsin属于少数机构,在这些机构中,非西班牙裔黑人患者比非西班牙裔白人患者更频繁地开出阿片类药物。本研究的目的是评估种族和民族在医疗保险患者处方实践中的差异,以确定干预的领域。方法:这是一项对接受门诊阿片类药物治疗疼痛的医疗保险成年患者的回顾性研究。结果包括处方数量和最大吗啡毫克当量(MME)。使用未调整和调整的线性回归模型来检查种族和民族之间的关系以及有无调整协变量的每个结果。结果:在研究期间,共有17105名患者获得了阿片类药物的门诊处方。虽然大多数处方是提供给非西班牙裔白人患者的,但非西班牙裔黑人患者的平均处方数更高(4.36;95% CI, 4.08 - 4.63), mme更高,为495.31 (95% CI, 445.72 - 544.91)。在控制了人口统计学和合并症后,个体合并症成为与更多处方相关的独立变量,如镰状细胞病(β 9.86; 95% CI, 9.08-10.64; PP < 0.001),药物滥用(β 5.22; 95% CI, 4.96-5.48; PP)。结论:机构应探讨阿片类药物使用种族不公平的原因。个体合并症与阿片类药物处方的差异有关,允许对这些患者群体进行有针对性的干预。
Drivers of Opioid Prescriptions for Medicare Patients at an Urban Tertiary Center.
Introduction: Froedtert & the Medical College of Wisconsin belongs to a minority of institutions in which opioids are more frequently prescribed to non-Hispanic Black patients than their non-Hispanic White counterparts. The objective of this study was to evaluate racial and ethnic differences in prescribing practices for Medicare patients to determine areas for intervention.
Methods: This was a retrospective review of adult patients with Medicare insurance who received an ambulatory opioid prescription for pain. Outcomes included number of prescriptions, and maximum morphine milligram equivalent (MME). Unadjusted and adjusted linear regression models were used to examine associations between race and ethnicity and each outcome with and without adjustments for covariates.
Results: A total of 17 105 patients were given an ambulatory opioid prescription over the study period. Although most prescriptions were provided to non-Hispanic White patients, non-Hispanic Black patients had a higher mean number of prescriptions (4.36; 95% CI, 4.08 - 4.63) and higher MMEs at 495.31 (95% CI , 445.72 - 544.91). After controlling for demographics and comorbidities, individual comorbidities emerged as independent variables associated with greater numbers of prescriptions, with sickle cell disease (β 9.86; 95% CI, 9.08-10.64; PP < 0.001), drug abuse (β 5.22; 95% CI, 4.96-5.48; PP < 0.001), and paralysis (β 2.20; 95% CI, 1.73-2.67; PP <0.001) having the strongest relationships, while after adjustment, the significance of race and ethnicity was lost.
Conclusions: Institutions should explore reasons for racially inequitable opioid receipt. Individual comorbidities were associated with differences in opioid prescribing, allowing for targeted interventions in these patient groups.